Will the EPO’s Enlarged Board hear the Broad’s CRISPR case?

“The Opposition Division’s interpretation of the European Patent Convention (EPC) is inconsistent with treaties designed to harmonise the international patent process, including that of the US and Europe.” This was the rather strong reaction of the Broad Institute (BI) after the European Patent Office’s (EPO) Opposition Division’s (OD) decision to revoke one of its CRISPR patents.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk